FrancophonIA/ELRC3.0 huggingface dataset:
English: * Not statistically significant (p ≥ 0.05).
Maltese: * Mhux statistikament sinifikanti (p ≥ 0.05).
English: A relationship between antibody responses to rotavirus vaccination and protection against rotavirus gastro-enteritis has not been established.
Maltese: Għadha ma ġietx stabbilita relazzjoni bejn rispons ta' anti-korpi għall vaċċinazzjoni bir-rotavirus u protezzjoni kontra l-gastro-enterite bir-rotavirus.
English: Based on evidence generated in clinical trials, breast-feeding does not reduce the protection against rotavirus gastro-enteritis afforded by Rotarix.
Maltese: Fuq bażi ta 'evidenza ġġenerata fi provi kliniċi, it-treddigħ ma jnaqqasx il-protezzjoni kontra l-gastroenterite tar-rotavirus mogħtija minn Rotarix.
English: 1 glass container: powder 1 oral applicator: solvent 1 transfer adapter 1 dose (1 ml)
Maltese: U KONTENUT Trab u solvent għal suspensjoni orali kontenitur tal-ħġieġ 1: trab applikatur tal-ħalq 1: solvent transfer adapter 1
English: < 3 yrs 3-11 m
Maltese: < 3 snin 3-11 m
English: Section 4.4 of the SmPC of Rotarix includes a warning on administration of Rotarix to infants who have known or suspected immunodeficiency.
Maltese: Sezzjoni 4.4 tal-SmPC ta' Rotarix tinkludi twissija dwar l-għoti ta' Rotarix lil trabi li għandhom immunodefiċjenza magħrufa jew suspettata.
English: Rotarix oral suspension in pre-filled oral applicator Rotarix oral suspension in squeezable tube
Maltese: Rotarix suspensjoni orali
English: 50 tubes 50 x 1 dose (1.5 ml)
Maltese: 50 x doża waħda (1.5 ml)
English: 10 tubes 10 x 1 dose (1.5 ml)
Maltese: 10 x doża waħda (1.5 ml)
English: Rotavirus vaccine, live
Maltese: Vaċċin ta' Rotavirus, ħaj
English: Viral antigen particles detected by ELISA were found in 50% of stools after the first dose and 4% of stools after the second dose.
Maltese: Frak antiġen virali skopert b'ELISA instab f'50% ta' ħmieġ solidu wara l-ewwel doża u f'4% ta' ħmieġ solidu wara t-tieni doża.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING PRE-FILLED ORAL APPLICATOR, PACK SIZE OF 1, 5, 10 OR 25
Maltese: U TRANSFER ADAPTER, PAKKETTI TA' 1, 5, 10 JEW 25
English: Neck
Maltese: Spike
English: QUALITATIVE AND QUANTITATIVE COMPOSITION After reconstitution, 1 dose (1 ml) contains:
Maltese: U KWANTITATTIVA Wara li tiġi rikostitwita, doża waħda (1 ml) ikun fiha:
English: • flatulence
Maltese: Effikaċja
English: Severity of gastro-enteritis was defined according to two different criteria: - the Vesikari 20-point scale, which evaluates the full clinical picture of rotavirus gastro-enteritis by taking into account the severity and duration of diarrhoea and vomiting, the severity of fever and dehydration as well as the need for treatment or - the clinical case definition based on World Health Organization (WHO) criteria
Maltese: Is-severità ta' gastro-enterite ġiet imfissra skont żewġ kriterji differenti: - l-iskala Vesikari ta' 20 punt li tevalwa l-istampa klinika sħiħa ta' gastro-enterite kkawżata minn rotavirus billi tikkalkula s-severità u t-tul ta' ħin ta' dijarea u rimettar, is-severità tad-deni u taddeidratazzjoni kif ukoll il-bżonn ta' kura jew - id-definizzjoni tal-każ kliniku bbażat fuq kriterji tal-Organizzazzjoni Dinjija tas-Saħħa (WHO)
English: EXPIRY DATE EXP {MM/YYYY}
Maltese: Impatt fuq rikoveru l-isptar§
English: MARKETING AUTHORISATION NUMBER(S) EU/1/05/330/012 - pack of 50 tubes 13.
Maltese: TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ EU/1/05/330/012 - pakkett ta' 50 tubu
English: Strains with P[8] genotype Circulating rotavirus strains Vaccine efficacy (%) against rotavirus gastro-enteritis requiring medical attention [95% CI]
Maltese: Razez tar-rotavirus fiċ-ċirkolazzjoni Effikaċja tal-vaċċin (%) kontra gastro-enterite bir-rotavirus li teħtieġ attenzjoni medika [95% CI]
English: EU/1/05/330/001 - pack of 1 (glass container + oral applicator + transfer adapter) EU/1/05/330/002 - pack of 5 (glass container + oral applicator + transfer adapter) EU/1/05/330/003 - pack of 10 (glass container + oral applicator + transfer adapter) EU/1/05/330/004 - pack of 25 (glass container + oral applicator + transfer adapter)
Maltese: EU/1/05/330/002 - pakkett ta' 5 (kontenitur tal-ħġieġ + applikatur tal-ħalq + transfer adapter)
English: Immune response
Maltese: Rispons immunitarju
English: The severe RV gastro-enteritis cases were due to RV strains G1P[8], G2P[4], G3P[8] and G9P[8].
Maltese: Każijiet ta' gastro-enterite severa kkawżata minn RV kienu dovuti għal razez ta' RV G1P[8], G2P[4], G3P[8] u G9P[8].
English: Breast-feeding
Maltese: Il-Brażil
English: Impact studies with Rotarix conducted in Panama, Brazil and Mexico showed a decrease in all-cause diarrhoea mortality ranging from 17% to 73% in children less than 5 years of age, within 2 to 4 years after vaccine introduction.
Maltese: Studji tal-impatt b'Rotarix li saru fil-Panama, il-Brażil u l-Messiku urew tnaqqis fil-mortalità mid dijarea mill-kawżi kollha, li kien ivarja minn 17% sa 73% fit-tfal ta' taħt il-5 snin, fi żmien sentejn sa
English: Official batch release:
Maltese: Il-frekwenzi huma rrappurtati bħala:
English: • Turn the cap upside down (180°).
Maltese: • Dawwar il-kappa 'l isfel (180 °).
English: Age range
Maltese: ANNESS IV
English: - Squeezable tube fitted with a membrane and a tube cap: 3 years
Maltese: - Applikatur orali mimlija minn qabel:3 snin - tubu li jista 'jiġi mbuttat mgħammar bi tubu tal-membrana u kappa: 3 snin
English: Rotarix may be given with the same posology to preterm infants born after at least 27 weeks of gestational age (see sections 4.8 and 5.1).
Maltese: Rotarix jista' jingħata bl-istess pożoloġija lit-trabi mwieldin qabel iż-żmien, wara mill-inqas 27 ġimgħa ta' tqala (ara sezzjonijiet 4.8 u 5.1).
English: - The other ingredients in Rotarix are: sucrose (see also section 2, Rotarix contains sucrose), Di sodium Adipate, Dulbecco's Modified Eagle Medium (DMEM), sterile water What Rotarix looks like and contents of the pack Oral suspension.
Maltese: - Is-sustanzi l-oħra f'Rotarix huma: sucrose (ara wkoll sezzjoni 2, Rotarix fih sucrose u sorbitol), Di-sodium Adipate, Dulbecco's Modified Eagle Medium (DMEM), ilma sterili
English: In general, the adverse event profile reported in these cases was similar to that observed after administration of the recommended dose of Rotarix.
Maltese: B'mod ġenerali, il-profil tal-avveniment avvers irrapportat f'dawn il-każijiet kien simili għal dak osservat wara amministrazzjoni tad-doża rrakkomandata ta' Rotarix.
English: Rotarix is supplied as clear and colourless liquid in 5 single dose squeezable tubes (5 x 1.5 ml) connected by a bar.
Maltese: Rotarix jinbiegħ bħala likwidu ċar u bla kulur f'tubu li jingħafas b'doża waħda (1.5ml).
English: • Hold the side of tube
Maltese: • Żomm in-naħa tat-tubu
English: Clinical studies have been conducted in Europe, Latin America, Africa and Asia to evaluate the protective efficacy of Rotarix against any and severe rotavirus gastro-enteritis.
Maltese: Twettqu studji kliniċi fl-Ewropa, fl-Amerika Latina, fl-Afrika u fl-Asja biex tiġi evalwata l-effikaċja protettiva ta' Rotarix kontra kull tip ta' gastro-enterite severi minn rotavirus.
English: Circulating rotavirus strains † Severe gastro-enteritis was defined as a score ≥11 on the Vesikari scale
Maltese: Gastro-enterite severa kienet definita bħala qari ta' ≥11 fuq l-iskala Vesikari
English: NAME OF THE MEDICINAL PRODUCT Rotarix powder and solvent for oral suspension Rotavirus vaccine, live
Maltese: Informazzjoni għall-utent Rotarix trab u solvent għal suspensjoni orali Vaċċin ta' rotavirus, ħaj
English: Human rotavirus RIX4414 strain (live, attenuated)
Maltese: Razza ta' rotavirus uman RIX4414
English: Vaccine efficacy (%) against rotavirus gastro-enteritis requiring hospitalisation and/or rehydration therapy in a medical facility [95% CI] Circulating rotavirus strains † Severe gastro-enteritis was defined as a score ≥11 on the Vesikari scale * Not statistically significant (p ≥ 0.05).
Maltese: Razez ta' rotavirus li qed jiċċirkolaw Effikaċja tat-tilqima (%) kontra gastro-enterite kkawżata minn rotavirus bi bżonn ta' dħul l-isptar u/jew terapija ta' idratazzjoni mill-ġdid f'faċilità medika [95% CI] Razez ta' rotavirus li qed jiċċirkolaw
English: Discard the empty tube and cap in approved biological waste containers according to local regulations.
Maltese: Armi t-tubu u l-kappa vojta f'kontenituri approvati ta 'skart bijoloġiku skond ir-regolamenti lokali.
English: Do not inject.
Maltese: Passat ta' intussuxezzjoni.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING TUBE, PACK SIZES OF 1, 10 OR 50
Maltese: TUBU, PAKKETTI TA' 1, 10 JEW 50
English: < 2 yrs 6-11 m
Maltese: < sentejn 6-11 m
English: Instructions for administration of the vaccine in a pre-filled oral applicator:
Maltese: Istruzzjonijiet għall-amministrazzjoni tal-vaċċin:
English: Any severity Severe†
Maltese: Kull tip ta' severità
English: All RVGE
Maltese: Razez
English: Pull
Maltese: Ponta
English: 25 pre-filled oral applicators 25 x 1 dose (1.5 ml)
Maltese: 25 x doża waħda (1.5 ml)
English: Dextran
Maltese: Treddigħ
English: Read the package leaflet before use.
Maltese: Mhux id-daqsijiet kollha tal-pakkett jistgħu jiġu kkummerċjalizzati.
English: • Provide, on a 6-month basis, updates on the progress being made on the activities set out in the implementation plan for the development of a PCV-free vaccine, as agreed by CHMP on 15 September 2016: every June and December until the PCV-free Rotarix application.
Maltese: kif miftiehem mis-CHMP fil-15 ta' Settembru 2016: kull Ġunju u Diċembru sal applikazzjoni ta' Rotarix ħieles mill-PCV.
English: Although concomitant administration of OPV may slightly reduce the immune response to rotavirus vaccine, clinical protection against severe rotavirus gastro-enteritis was shown to be maintained in a clinical trial involving more than 4,200 subjects who received Rotarix concomitantly with OPV.
Maltese: Għalkemm meta l-OPV tingħata fl-istess ħin, tista' tnaqqas ftit ir rispons immunitarju għall-vaċċin tar-rotavirus, il-protezzjoni klinika kontra gastro-enterite severi mirrotavirus tibqa' u dan intwera fi prova klinika fejn kienu involuti aktar minn 4,200 persuna li rċivew Rotarix flimkien ma' OPV.
English: 5 pre-filled oral applicators 5 x 1 dose (1.5 ml)
Maltese: 5 x doża waħda (1.5 ml)
English: When a person is given the vaccine, the immune system (the body's natural defences) will make antibodies against the most commonly occurring types of rotavirus.
Maltese: Meta persuna tingħata l-vaċċin, is-sistema immunitarja (ir-reżistenza naturali tal-ġisem) toħloq anti korpi kontra l-aktar tipi komuni ta' rotavirus.
English: Since the immune response observed after 2 doses of Rotarix liquid formulation was comparable to the immune response observed after 2 doses of Rotarix lyophilised formulation, the levels of vaccine efficacy observed with the lyophilised formulation can be extrapolated to the liquid formulation.
Maltese: Peress li r-rispons immunitarju osservat wara 2 dożi ta' Rotarix fil-forma likwida kienet komparabbli għar-rispons osservat wara 2 dożi ta' Rotarix fil-forma lajofiliżżata, l-livell ta' effikaċja tal-vaċċin osservat bil-forma lajofiliżżata jista' jiġi estrapolat għal forma likwida.
English: • if your child has a rare inherited illness which affects their immune system called Severe Combined Immunodeficiency (SCID).
Maltese: • jekk it-tifel / tifla tiegħek għandu marda rari li tintiret li taffettwa s-sistema immuni tagħhom imsejħa Immunodefiċjenza Magħquda Severa (SCID).
English: It remains unclear whether rotavirus vaccines affect the overall incidence of intussusception based on longer periods of follow-up (see section 4.4).
Maltese: Għandu mhuwiex ċar jekk it-tilqim ta' rotavirus jaffettwax l-inċidenza totali ta' intussuxxezzjoni abbażi ta' perjodi itwal ta' segwitu (ara sezzjoni 4.4).
English: Taking into account the PRAC Assessment Report on the PSUR(s) for rotavirus vaccine monovalent (live, oral), the scientific conclusions of CHMP are as follows:
Maltese: Meta jiġi kkunsidrat ir-Rapport ta' Valutazzjoni tal-PRAC dwar il-PSUR(s) għal vaċċin tar-rotavirus monovalenti (ħaj, orali), il-konklużjonijiet xjentifiċi tas-CHMP huma kif ġej:
English: ANNEX II
Maltese: ANESS II
English: Abdominal pain, flatulence
Maltese: Uġigħ fl-addome, gass
English: Rotarix oral suspension in squeezable tube Rotavirus vaccine, live
Maltese: Trab għal suspensjoni orali Vaċċin tar-rotavirus, ħaj
English: The vaccine contains sucrose and sorbitol as excipients.
Maltese: Il-vaċċin fih sucrose u sorbitol bħala sustanzi mhux attivi.
English: Rotarix oral suspension in multi-monodose (5 single dose) squeezable tube presentation connected by a bar Rotavirus vaccine, live
Maltese: Sospensjoni orali ta' Rotarix f'formazzjoni ta' tubu squeezable multi-monodose (5 doża waħda) konnessa minn bar
English: Dispose of in accordance with local regulations.
Maltese: Armi skond ir-regolamenti lokali.
English: The immunologic mechanism by which Rotarix protects against rotavirus gastro-enteritis is not completely understood.
Maltese: Il-mekkaniżmu immunoloġiku li bih Rotarix jipproteġi kontra l-gastro-enterite bir-rotavirus għadu mhux mifhum biżżejjed.
English: Latvija GlaxoSmithKline Latvia SIA
Maltese: Magyarország GlaxoSmithKline Kft. Tel.:
English: To open the separated oral tube: d) Keep the separated oral tube held upright.
Maltese: Biex tiftaħ it-tubu orali separat:
English: This was supported by a very short time-to-onset (from immediate onset to a few hours), the absence of coadministered vaccines or drugs, and the rapid resolution of the event, with or without treatment.
Maltese: Dan ġie appoġġjat minn żmien qasir ħafna għall-bidu (mill-bidu immedjat sa ftit sigħat), in-nuqqas ta' vaċċini jew mediċini mogħtija flimkien, u l-fejqan rapidu tal-avveniment, bi jew mingħajr kura.
English: • Check the liquid is clear and colourless, without any particles in it.
Maltese: • Iċċekkja li t-tubu ma ġiex imħassar u lanqas ma huwa diġà miftuħ.
English: Ísland ςιστορ ηφ.
Maltese: Dawn ir-razez qed jiċċirkulaw mad-dinja kollha.
English: Strains with P[8] genotype
Maltese: Razez b'ġenotip P[8]
English: Besides, the SmPC of immunosuppressive therapies, such as adalimumab, infliximab, includes a recommendation to defer live vaccine administration in infants who were exposed in utero to these treatments.
Maltese: Barra minn hekk, l-SmPC ta' terapiji immunosoppressivi, bħal adalimumab, infliximab, jinkludi rakkomandazzjoni biex jiġi pospost l-għoti ta' vaċċin ħaj fi trabi li ġew esposti in utero għal dawn il-kuri.
English: In two comparative controlled trials, vaccine shedding after vaccination with Rotarix liquid formulation was comparable to that observed after vaccination with Rotarix lyophilised formulation.
Maltese: F'tlett provi kliniċi komparattivi, Rotarix fil-forma likwida qanqal rispons immunitarju komparabbli għal dik minn Rotarix fil-forma lajofiliżżata
English: Taiwan were calculated using combined rotavirus-negative hospital control and non-diarrhoea hospital control participants).
Maltese: (stimi mit-Tajwan ġew ikkalkulati bl-użu ta' parteċipanti ta' kontroll mill-isptar negattivi għar-rotavirus u ta' parteċipanti ta' kontroll mill-isptar ta' bla dijarea).
English: (6) In subjects who did not receive the full course of vaccination, the effectiveness after one dose ranged from 51% (95% CI: 26;67, El Salvador) to 60% (95% CI: 37;75, Brazil).
Maltese: F'individwi li ma rċevewx il-kors sħiħ tat-tilqima, l-effikaċja wara doża waħda kienet tvarja minn 51% (95% CI: 26;67 El Salvador) sa 60 %
English: MARKETING AUTHORISATION NUMBER(S) EU/1/05/330/009 - pack of 1 tube EU/1/05/330/010 - pack of 10 tubes EU/1/05/330/011 - pack of 50 tubes
Maltese: TAL-AWTORIZZAZZJONI GĦAT-TQEGĦID FIS-SUQ EU/1/05/330/009 - pakkett ta' tubu 1
English: Rotarix is a viral vaccine, containing live, attenuated human rotavirus, that helps to protect your child, from the age of 6 weeks, against gastro-enteritis (diarrhoea and vomiting) caused by rotavirus infection.
Maltese: Rotarix hu vaċċin virali, li fih rotavirus uman attenwat, li jgħin billi jipproteġi t-tarbija tiegħek, milletà ta' sitt ġimgħat, kontra l-gastro-enterite (dijarea u rimettar) kawżata minn infezzjoni ta' rotavirus.
English: Strains with P[6] genotype
Maltese: Razez bil-ġenotip P[6]
English: The protective vaccine efficacy (pooled doses) observed against any and severe rotavirus gastro-enteritis is presented in the following table:
Maltese: L-effikaċja protettiva tat-tilqima (ġabra ta' dożi) osservata kontra kwalunkwe gastro-enterite u gastroenterite qawwija kkawżati minn rotavirus hija ppreżentata fit-tabella li ġejja:
English: Strains with P[8] genotype † Severe rotavirus gastro-enteritis was defined as an episode of diarrhoea with or without vomiting that required hospitalization and/or re-hydration therapy in a medical facility (WHO criteria) * Not statistically significant (p ≥ 0.05).
Maltese: Gastro-enterite severa kienet definita bħala episodju ta' dijarea bi jew mingħajr rimettar bi bżonn ta' dħul l-isptar u/jew terapija ta' idratazzjoni f'faċilità medika (kriterja WHO)
English: In addition, nine impact studies on all-cause diarrhoea hospitalisation conducted in Africa and Latin America showed a reduction of 14% to 57% between 2 and 5 years after vaccine introduction.
Maltese: Barra minn hekk, disa' studji tal-impatt dwar rikoveru l-isptar minħabba dijarea mill-kawżi kollha, li saru fl-Afrika u fl-Amerika Latina, urew tnaqqis ta' 14% sa 57% bejn sentejn u 5 snin wara lintroduzzjoni tal-vaċċin.
English: Grounds for the variation to the terms of the marketing authorisation(s) On the basis of the scientific conclusions for rotavirus vaccine monovalent (live, oral) the CHMP is of the opinion that the benefit-risk balance of the medicinal product(s) containing rotavirus vaccine monovalent (live, oral) is unchanged subject to the proposed changes to the product information The CHMP recommends that the terms of the marketing authorisation(s) should be varied.
Maltese: Raġunijiet għall-varjazzjoni għat-termini tal-Awtorizzazzjoni(jiet) għat-Tqegħid fis-Suq Abbażi tal-konklużjonijiet xjentifiċi vaċċin tar-rotavirus monovalenti (ħaj, orali) is-CHMP huwa talfehma li l-bilanċ bejn il-benefiċċju u r-riskju ta' prodott(i) mediċinali li fih/fihom vaċċin tar-rotavirus monovalenti (ħaj, orali) huwa favorevoli suġġett għall-bidliet proposti għall-informazzjoni tal-prodott.
English: Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this vaccine.
Maltese: Pazjenti bi problemi ereditarji rari ta' nuqqas ta' tolleranza għal fruttosju, malassorbiment ta' glukosju-galattosju jew nuqqas ta' sucraseisomaltase m'għandomx jieħdu dan il-vaċċin.
English: Adverse reactions reported are listed according to the following frequency:
Maltese: Ir-reazzjonijiet avversi rrappurtati huma elenkati skont il-frekwenza li ġejja:
English: • pack size of 5 glass containers of powder plus 5 oral applicators of solvent
Maltese: • daqs ta' pakkett ta' 5 kontenituri tal-ħġieġ għat-trab flimkien ma' 5 applikaturi tal-ħalq tas-solvent
English: • pack size of 10 glass containers of powder plus 10 oral applicators of solvent
Maltese: • daqs ta' pakkett ta' 10 kontenituri tal-ħġieġ għat-trab flimkien ma' 10 applikaturi tal-ħalq tassolvent
English: • pack size of 25 glass containers of powder plus 25 oral applicators of solvent
Maltese: • daqs ta' pakkett ta' 25 kontenitur tal-ħġieġ għat-trab flimkien ma' 25 applikaturi tal-ħalq tassolvent
English: Excipients with known effect:
Maltese: Data ta' Skadenza:
English: The protective vaccine efficacy against severe rotavirus (RV) gastro-enteritis requiring hospitalisation and/or rehydration therapy in a medical facility and the genotype specific vaccine efficacy after two doses of Rotarix are presented in the table below:
Maltese: L-effikaċja protettiva tal-vaċċin kontra gastro-enterite bir-rotavirus (RV) severi li kienet tinħtieġ trattament fi sptar u/jew terapija ta' reidrazzjoni ġo faċilità medika u l-effikaċja tal-vaċċin skont il-ġenotip speċifiku wara żewġ dożi ta' Rotarix jidhru fit-tabella t'hawn taħt:
English: Circulating rotavirus strains
Maltese: Gastro-enterite severi birrotavirus†
English: Transfer adapter for reconstitution (1/dose) in the following pack sizes:
Maltese: Transfer adapter għar-rikostituzzjoni (doża waħda) fid-daqsijiet ta' pakketti li ġejjin:
English: Oral administration only
Maltese: Orali amministrazzjoni biss
English: G1P[8] G2P[4] G3P[8] G8P[4] G9P[8] G12P[6] Strains with P[4] genotype Strains with P[6] genotype Strains with P[8] genotype † Severe gastro-enteritis was defined as a score ≥11 on the Vesikari scale * Not statistically significant (p ≥ 0.05).
Maltese: Fi studji ta' osservazzjoni, l-effikaċja tal-vaċċin intweriet kontra gastro-enterite severa li wasslet għal rikoveru l-isptar minħabba rotavirus ta' ġenotipi komuni G1P[8], G2P[4], G3P[8], G4P[8] u G9P[8] kif ukoll il-ġenotipi ta' rotavirus l-inqas komuni G9P[4] u G9P[6].
English: LIST OF EXCIPIENTS Sucrose
Maltese: Trab Sucrose Dextran Sorbitol
English: Pre-filled oral applicator
Maltese: KLASSIFIKAZZJONI ĠENERALI
English: Then wash hands with clean water.
Maltese: TAL-PRODOTT,
English: Reference: Adapted from 1) Foley KM.
Maltese: Adattata minn 1) Foley KM.
English: NEJM 1985; 313 (2): 84-95 and 2) McPherson ML.
Maltese: NEJM 1985; 313 (2): 84-95 u 2) McPherson ML. Introduction to opioid conversion calculations.
English: cyproheptadine, diphenhydramine, or hydroxyzine).
Maltese: cyproheptadine, diphenhydramine, jew hydroxyzine).
English: Linearity/non-Linearity
Maltese: Linearità/nuqqas ta' linearità
English: Monoamine Oxidase Inhibitors (MAOI)
Maltese: Inibituri ta' Monoamine Oxidase (MAOI)
English: • Hold for at least 30 seconds.
Maltese: • Żomm għal mill-inqas 30 sekonda.
English: Patients with myasthenia gravis
Maltese: Pazjenti b'myasthenia gravis
English: escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, or venlafaxine).
Maltese: duloxetine, escitalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, jew venlafaxine).
English: 0.23b diamorphine oral parenteral
Maltese: 0.23b diamorphine orali parenterali
English: 15b methadone oral parenteral
Maltese: 15b methadone orali parenterali
English: Tolerance, physical dependence, and psychological dependence may develop upon repeated administration of opioids.
Maltese: Tolleranza, dipendenza fiżika, u dipendenza psikoloġika jistgħu jiżviluppaw bl-użu ripetut ta'
English: Bradypnoea
Maltese: Bradipnea
English: Multiplication Factor morphine oral
Maltese: Fattur ta' Multiplikazzjoni morphine orali
English: Respiratory depression, Respiratory distress
Maltese: Depressjoni respiratorja, Diffikultà respiratorja
English: (see Table 2).
Maltese: (ara sezzjoni 4.8).
English: 30b pethidine oral parenteral
Maltese: 30b pethidine orali parenterali
English: Palpitations, Tachycardia
Maltese: Palpitazzjonijiet, Takikardija
English: Central nervous system depressants may increase the respiratory depression (see section 4.5).
Maltese: Depressanti tas-sistema nervuża ċentrali jistgħu jżidu d-depressjoni respiratorja (ara sezzjoni 4.5).
English: Serotonin syndrome
Maltese: Sindrom tas-serotonin
English: 3b oxycodone oral parenteral oxymorphone rectal parenteral
Maltese: 3b oxycodone orali parenterali oxymorphone mir-rektum parenterali
English: 6b fentanyl oral parenteral hydromorphone oral parenteral
Maltese: 6b fentanyl orali parenterali hydromorphone orali parenterali
English: Operations
Maltese: Operazzjonijiet
English: Severe respiratory depression.
Maltese: Depressjoni respiratorja severa.
English: The major metabolite, norfentanyl, and other metabolites are inactive.
Maltese: Il-metabolit prinċipali, norfentanyl, u metaboliti oħra mhumiex attivi.
English: 20b ketobemidone oral parenteral levorphanol oral parenteral
Maltese: 20b ketobemidone orali parenterali levorphanol orali parenterali